Cipla promoters sell 2.53% stake in company for Rs 2,637 cr

Mumbai: The promoters of Cipla have sold a 2.53% stake in the company for 'creating liquidity' for specific needs including 'philanthropy', the Mumbai headquartered pharma major said on Wednesday.

Cipla Q4FY24: Net profit grows 79% YoY to Rs 939 cr

Mumbai: Pharma giant Cipla’s consolidated net profit grew 79% rising to Rs 939.04 crore in Q4 FY24 over Q4 FY23.

Sanofi partners with Cipla to distribute and promote its Central Nervous System product range in India

Mumbai: Pharma companies Sanofi India and Cipla Limited on Tuesday announced an exclusive partnership for the distribution and promotion of Sanofi India’s Central Nervous System (CNS) product range in India.

Cipla's portable, wireless spirometer to ease diagnosis of COPD, asthma

Mumbai/IBNS: Indian multinational pharma giant Cipla Limited  (BSE:  500087;  NSE:  CIPLA  EQ)  Wednesday announced  the launch  of  Spirofy, India's first pneumotach based portable, wireless spirometer, on World COPD Day, the company said in a BSE filing.

Cinacalcet tablets case: Cipla, Amgen settle legal dispute

Mumbai/UNI: Pharma major, Cipla on Monday said company has settled a a legal dispute with Amgen in the United States involving generic cinacalcet hydrochloride tablets , used in treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease.